These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20306448)

  • 1. An alternative cyclin-D1 splice site is not linked to inflammatory bowel disease-associated neoplasia.
    Kanaan Z; Eichenberger MR; Young M; Colliver D; Crawford N; Cobbs GA; Hein DW; Galandiuk S
    Int J Biol Markers; 2010; 25(1):27-31. PubMed ID: 20306448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ulcerative colitis neoplasia is not associated with common inflammatory bowel disease single-nucleotide polymorphisms.
    Connelly TM; Berg AS; Harris LR; Brinton DL; Hegarty JP; Deiling SM; Stewart DB; Koltun WA
    Surgery; 2014 Aug; 156(2):253-62. PubMed ID: 24947639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin D1 A870G polymorphism and the risk of colorectal cancer and adenoma.
    Schernhammer ES; Tranah GJ; Giovannucci E; Chan AT; Ma J; Colditz GA; Hunter DJ; Willett WC; Fuchs CS
    Br J Cancer; 2006 Mar; 94(6):928-34. PubMed ID: 16495921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary Colorectal Cancer Syndromes and Inflammatory Bowel Diseases: an ECCO CONFER Multicentre Case Series.
    Barberio B; Savarino E; Verstockt B; Fumery M; Pugliese D; Bertani L; Buda A; Dragoni G; Goren I; Laish I; Spinelli A; Teich N; Truyens M; Ellul P
    J Crohns Colitis; 2022 Dec; 16(12):1845-1852. PubMed ID: 35771951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin D1 A870G polymorphism in Brazilian colorectal cancer patients.
    Forones NM; de Lima JM; de Souza LG; da Silva ID
    J Gastrointest Cancer; 2008; 39(1-4):118-23. PubMed ID: 19373442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of cyclin D1 A870G polymorphism on colorectal cancer risk and prognosis in a Turkish population.
    Yaylim-Eraltan I; Arikan S; Yildiz Y; Cacina C; Ergen HA; Tuna G; Görmüs U; Zeybek U; Isbir T
    Anticancer Res; 2010 Jul; 30(7):2875-80. PubMed ID: 20683026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of T Helper 1 Cytokine Gene Single Nucleotide Polymorphisms with Ulcerative Colitis and Crohn's Disease.
    Ebrahimi Daryani N; Sadr M; Soltani S; Saghazadeh A; Moossavi S; Shahkarami S; Farhadi E; Rezaei N
    Dig Dis; 2019; 37(1):21-32. PubMed ID: 30134230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphism of ABCB1 gene (C3435T) in patients with inflammatory bowel diseases. Is there any gender dependency?
    Jaźwińska-Tarnawska E; Jęśkowiak I; Waszczuk E; Mulak A; Głowacka K; Hurkacz M; Paradowski L; Zaleska Z; Wiela-Hojeńska A
    Pharmacol Rep; 2015 Apr; 67(2):294-8. PubMed ID: 25712653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin D1 protein expression and gene polymorphism in colorectal cancer. Aberdeen Colorectal Initiative.
    McKay JA; Douglas JJ; Ross VG; Curran S; Murray GI; Cassidy J; McLeod HL
    Int J Cancer; 2000 Oct; 88(1):77-81. PubMed ID: 10964085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic characterization of colitis-associated colorectal cancer.
    Kameyama H; Nagahashi M; Shimada Y; Tajima Y; Ichikawa H; Nakano M; Sakata J; Kobayashi T; Narayanan S; Takabe K; Wakai T
    World J Surg Oncol; 2018 Jul; 16(1):121. PubMed ID: 29966533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a common variant with potential pleiotropic effect on risk of inflammatory bowel disease and colorectal cancer.
    Khalili H; Gong J; Brenner H; Austin TR; Hutter CM; Baba Y; Baron JA; Berndt SI; Bézieau S; Caan B; Campbell PT; Chang-Claude J; Chanock SJ; Chen C; Hsu L; Jiao S; Conti DV; Duggan D; Fuchs CS; Gala M; Gallinger S; Haile RW; Harrison TA; Hayes R; Hazra A; Henderson B; Haiman C; Hoffmeister M; Hopper JL; Jenkins MA; Kolonel LN; Küry S; LaCroix A; Marchand LL; Lemire M; Lindor NM; Ma J; Manson JE; Morikawa T; Nan H; Ng K; Newcomb PA; Nishihara R; Potter JD; Qu C; Schoen RE; Schumacher FR; Seminara D; Taverna D; Thibodeau S; Wactawski-Wende J; White E; Wu K; Zanke BW; Casey G; Hudson TJ; Kraft P; Peters U; Slattery ML; Ogino S; Chan AT;
    Carcinogenesis; 2015 Sep; 36(9):999-1007. PubMed ID: 26071399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of N-acetyltransferase 1 and 2 polymorphisms and haplotype analysis for inflammatory bowel disease and sporadic colorectal carcinoma.
    Mahid SS; Colliver DW; Crawford NP; Martini BD; Doll MA; Hein DW; Cobbs GA; Petras RE; Galandiuk S
    BMC Med Genet; 2007 May; 8():28. PubMed ID: 17537267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the inducible nitric oxide synthase gene (NOS2A) on inflammatory bowel disease susceptibility.
    Martín MC; Martinez A; Mendoza JL; Taxonera C; Díaz-Rubio M; Fernández-Arquero M; de la Concha EG; Urcelay E
    Immunogenetics; 2007 Nov; 59(11):833-7. PubMed ID: 17955236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of cyclin D1 (CCND1) and E-cadherin (CDH1) alterations to colorectal cancer susceptibility: a case-control study.
    Govatati S; Singamsetty GK; Nallabelli N; Malempati S; Rao PS; Madamchetty VK; Govatati S; Kanapuram R; Narayana N; Bhanoori M; Kassetty K; Nallanchakravarthula V
    Tumour Biol; 2014 Dec; 35(12):12059-67. PubMed ID: 25146682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rates and characteristics of postcolonoscopy colorectal cancer in the Swedish IBD population: what are the differences from a non-IBD population?
    Stjärngrim J; Ekbom A; Hammar U; Hultcrantz R; Forsberg AM
    Gut; 2019 Sep; 68(9):1588-1596. PubMed ID: 30554159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between cyclin D1 (A870G) gene polymorphism and lung cancer.
    Cakina S; Gulyasar T; Ozen A; Sipahi T; Kocak Z; Sener S
    Indian J Biochem Biophys; 2013 Jun; 50(3):233-6. PubMed ID: 23898488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
    Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients' knowledge and fear of colorectal cancer risk in inflammatory bowel disease.
    Lopez A; Collet-Fenetrier B; Belle A; Peyrin-Biroulet L
    J Dig Dis; 2016 Jun; 17(6):383-91. PubMed ID: 27129893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic association and phenotypic correlation of TLR4 but not NOD2 variants with Tunisian inflammatory bowel disease.
    Feki S; Bouzid D; Abida O; Chtourou L; Elloumi N; Toumi A; Hachicha H; Amouri A; Tahri N; Masmoudi H
    J Dig Dis; 2017 Nov; 18(11):625-633. PubMed ID: 29055077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Factors Interact With Tobacco Smoke to Modify Risk for Inflammatory Bowel Disease in Humans and Mice.
    Yadav P; Ellinghaus D; Rémy G; Freitag-Wolf S; Cesaro A; Degenhardt F; Boucher G; Delacre M; ; Peyrin-Biroulet L; Pichavant M; Rioux JD; Gosset P; Franke A; Schumm LP; Krawczak M; Chamaillard M; Dempfle A; Andersen V
    Gastroenterology; 2017 Aug; 153(2):550-565. PubMed ID: 28506689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.